These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18362017)

  • 1. Anti-arrhythmic effects of statins: a hypothesis remains to be tested.
    Guo HM
    Heart Rhythm; 2008 Apr; 5(4):511-2. PubMed ID: 18362017
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction.
    Coleman CI; Kluger J; Bhavnani S; Clyne C; Yarlagadda R; Guertin D; White CM
    Heart Rhythm; 2008 Apr; 5(4):507-10. PubMed ID: 18362016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?
    Beri A; Contractor T; Khasnis A; Thakur R
    Am J Cardiovasc Drugs; 2010; 10(3):155-64. PubMed ID: 20524717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the arrhythmic risk of patients with ischaemic cardiomyopathy really benefit from revascularisation therapy?
    Kallergis EM; Mavrakis HE; Vardas PE
    Hellenic J Cardiol; 2008; 49(4):203-6. PubMed ID: 18935706
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
    Doherty JU; Fuchs S; Tecce MA
    Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
    Wanahita N; Chen J; Bangalore S; Shah K; Rachko M; Coleman CI; Schweitzer P
    Am J Ther; 2012 Jan; 19(1):16-23. PubMed ID: 20720485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable defibrillators in ischaemic cardiomyopathy: should women be treated differently to men?
    Leung DY
    Heart; 2014 Feb; 100(3):190-1. PubMed ID: 24270745
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators.
    Aronow WS
    Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias.
    Abuissa H; O'Keefe JH; Bybee KA
    Clin Cardiol; 2009 Oct; 32(10):549-52. PubMed ID: 19816987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Dickinson MG; Ip JH; Olshansky B; Hellkamp AS; Anderson J; Poole JE; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2007 Apr; 153(4):573-8. PubMed ID: 17383296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.
    Proclemer A; Bongiorni MG; Dagres N; Sciaraffia E; Todd D; Blomstrom-Lundqvist C;
    Europace; 2015 Jun; 17(6):994-8. PubMed ID: 26023178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators.
    Curtis AB
    J Am Coll Cardiol; 2004 Jan; 43(1):44-6. PubMed ID: 14715181
    [No Abstract]   [Full Text] [Related]  

  • 17. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute myocardial ischemia and ventricular arrhythmias in the pathogenesis of sudden cardiac death in coronary disease].
    Zehender M; Faber T; Brunner M; Grom A
    Z Kardiol; 2000; 89 Suppl 3():13-23. PubMed ID: 10810781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do traditional VT zones improve outcome in primary prevention ICD patients?
    Duncan E; Thomas G; Johns N; Pfeffer C; Appanna G; Shah N; Hunter R; Finlay M; Schilling RJ; Sporton S
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1353-8. PubMed ID: 20727095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.